W e studied 15 girls and 1 boy with CPP, divided in 2 groups according to BA in the momentl of withdrawn of treatment (tto). In group A the tto was stopped with B A between 11 and 12.91 years and group 13 between 13 and 15 years. BA and nature were obtained in 3 differenu occasions: at beginning, at the end of tto and in the last evaluation (mean 2 years after tto~ was stopped). Stature was expressed in standard-deviation score related to BA: Zs. Results::
In group A the differences between patients Zs and parents stature were: 0.003. -0.11 + respectively in the first, second and third evaluation. In group B these values were -4.53, 4 1.12. -0.53:
M e a n -0. 0. Monte. P e d i a t r i c E n d o c r i n o l . U n i t . S a n t a Casa Sao Paulo. B r a s i l . P a t i e n t s w i t h u n i l a t e r a l v a r i c o c e l e , g r a d e 3. (n-11). H e r e a n a l y -
z e d t o s t u d y if t h e r e a r e m o r p h o l o g i c a l o r f u c t i o n a l a l t e r a t i o n s i n t h e t e s t e s . They were c l a s s i f i e d a c c o r d i n g t o g e n i t a l s t a g e g i v e n
GnRH (1BB mcg) a n d hCG (56 U/kg/dose. 5 days) and u n d e w e n t b i l a t er a l t e s t i c u l a r b i o p s y . T e s t i c u l a r volume (TV) was measured a n d d i f f e r e n c e s > 2 cm3 were c o n s i d e r e d s i g n i f i c a n t B a s a l t e s t o t e r o n e ( T ) and peak LH. FSH a n d T were s i m i l a r to t h e c o n t r o l group. There was n o d i f f e r e n c e i n b a s a l LH and FSH between g r o u p s GI. G2. G3+4.
T u b u l a r d i a m e t e r (TD) a n d a r e a (TA) a r e showed i n t h e t a h l e . 
n t h e f i v e c a s e s w i t h decreased t e s t i c u l a r volume. t h e r e was a h i g h e r l Q o n t h e Va s i d e . S i x p a t i e n t s d i d n ' t have a r e d u c t i o n i n t e s t i c u l a r volume a n d o n l y t w o h a d a d i f f e r e n c e i n TD between b o t h s i d e s .
There was a t e n d e n c y f o r a decrease i n t e s t i c u l a r volume a n d an i n c r e a s e i n TD a d v a n c i n g p u b e r t a l development. 
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Congenital adrenal hyperplasla due to 3P-HSD deficlency may be classified in 2 clinical subtypes: the Llassical form-with or without salt-loss and a non classical form described in pubertal hirsute females Bnd in girls wlth premature pubarche. Recently the complete structure of the hvo human 3P-HSD genes type I and type It) have been character~zed. The type I1 gene encodes the 3P-HSD enzyme in the drenal glands, ovary and testis whereas the type I gene encodes the 3P-HSD enzyme in the placenta nd peripheral tlssue. We descrlbe here the first case with non classical 3p-HSD deficiency due lo a olnt mutation in 3-p-HSD type II. The patient, a 5-year-old white girl presented, with pubic hair, acne nd normal external gentlal~a. Her parents were not consanguineous and denied similar cases in the amily. CA 5.3 yrs. Height 111 cm (+0.1 SD) Weight23 kg: Bone agc5.75 ys; Breasts:Tanner I: Pubic i (hair: Tanner Ill.
The ACTH test (25 IU iv) found normal corttsol levels and hrgh levels of ~"steroids: DHEA.17PREG 'and 17PREGll70HP ratio.The A4-steroids 170HP. A4-A and T were also elevated. 24 hours basal 'urinary steroids were analyzed by gas chromatography and revealed elevated pregnenetrtol(5PT)=715 :p$24hs (NL:8O-352) and SPT/lHE+THF+SaTHF ratio=0.96 (NL:0.05) confirming the 30-HSD deficlency. The treatment with DEX 0.2 mg reversed all the steroid abnormalit~es.The 4 exons of the 'type II 3P-HDS gene were amplified by PCR and screened for mutations by denaturing gradiente gel eletrophoresis (DGGE). DGGE detected a mutation in exon 3 of 3P-HSD type II. Sequencing showed the mutation to be a single missense mutation of GCC-ACC In codon 82 leading to the substitution in the affected patient of threonine for the normal aianine. The patient is homozygous f a the mutation and her parents are both heterozygous. We conclude that non-classical form of 3P-HSD deficiency could also be caused by Doint mutatton in 30-HSD type II gene as in the classical form. 
